In the aftermath of recent sterile compounding errors—from the 2012 New England Compounding Center meningitis outbreak that sickened over 750 people and resulted in the death of 64, to an event in 2014 that took a woman’s life at a hospital in Bend, Ore.—health care organizations have begun enlisting barcoding, gravimetrics and other high-tech tools to enhance the safety of their IV products.
Yet even more should be following suit to protect patients, according to a panel of